Baillie Gifford's position in Moderna is currently worth $5.73 Billion. That's 4.46% of their equity portfolio (5th largest holding). The investor owns 12.19% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on eight occasions. The stake costed the investor $5.68 Billion, netting the investor a gain of 0.9% so far.